Correlation Between ZyVersa Therapeutics and Carmell Therapeutics
Can any of the company-specific risk be diversified away by investing in both ZyVersa Therapeutics and Carmell Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ZyVersa Therapeutics and Carmell Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ZyVersa Therapeutics and Carmell Therapeutics, you can compare the effects of market volatilities on ZyVersa Therapeutics and Carmell Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ZyVersa Therapeutics with a short position of Carmell Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ZyVersa Therapeutics and Carmell Therapeutics.
Diversification Opportunities for ZyVersa Therapeutics and Carmell Therapeutics
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between ZyVersa and Carmell is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding ZyVersa Therapeutics and Carmell Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Carmell Therapeutics and ZyVersa Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ZyVersa Therapeutics are associated (or correlated) with Carmell Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Carmell Therapeutics has no effect on the direction of ZyVersa Therapeutics i.e., ZyVersa Therapeutics and Carmell Therapeutics go up and down completely randomly.
Pair Corralation between ZyVersa Therapeutics and Carmell Therapeutics
Given the investment horizon of 90 days ZyVersa Therapeutics is expected to under-perform the Carmell Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, ZyVersa Therapeutics is 1.13 times less risky than Carmell Therapeutics. The stock trades about -0.07 of its potential returns per unit of risk. The Carmell Therapeutics is currently generating about -0.05 of returns per unit of risk over similar time horizon. If you would invest 315.00 in Carmell Therapeutics on September 2, 2024 and sell it today you would lose (285.00) from holding Carmell Therapeutics or give up 90.48% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
ZyVersa Therapeutics vs. Carmell Therapeutics
Performance |
| Timeline |
| ZyVersa Therapeutics |
| Carmell Therapeutics |
ZyVersa Therapeutics and Carmell Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ZyVersa Therapeutics and Carmell Therapeutics
The main advantage of trading using opposite ZyVersa Therapeutics and Carmell Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ZyVersa Therapeutics position performs unexpectedly, Carmell Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Carmell Therapeutics will offset losses from the drop in Carmell Therapeutics' long position.| ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Immix Biopharma | ZyVersa Therapeutics vs. Hepion Pharmaceuticals | ZyVersa Therapeutics vs. Zura Bio Limited |
| Carmell Therapeutics vs. Western Acquisition Ventures | Carmell Therapeutics vs. Bill Com Holdings | Carmell Therapeutics vs. Equinix | Carmell Therapeutics vs. Rumble Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |